These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36787293)

  • 21. Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    Morris JK; Uy RAZ; Vidoni ED; Wilkins HM; Archer AE; Thyfault JP; Miles JM; Burns JM
    J Alzheimers Dis; 2017; 58(4):1129-1135. PubMed ID: 28550261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's risk.
    Mosconi L; Williams S; Carlton C; Zarate C; Boneu C; Fauci F; Ajila T; Nerattini M; Jett S; Andy C; Battista M; Pahlajani S; Osborne J; Brinton RD; Dyke JP
    Sci Rep; 2024 Mar; 14(1):5519. PubMed ID: 38448497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
    Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.
    Xu G; McLaren DG; Ries ML; Fitzgerald ME; Bendlin BB; Rowley HA; Sager MA; Atwood C; Asthana S; Johnson SC
    Brain; 2009 Feb; 132(Pt 2):383-91. PubMed ID: 18829694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.
    Conejero-Goldberg C; Hyde TM; Chen S; Dreses-Werringloer U; Herman MM; Kleinman JE; Davies P; Goldberg TE
    Mol Psychiatry; 2011 Aug; 16(8):836-47. PubMed ID: 20479757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
    Shang Y; Mishra A; Wang T; Wang Y; Desai M; Chen S; Mao Z; Do L; Bernstein AS; Trouard TP; Brinton RD
    PLoS One; 2020; 15(1):e0225392. PubMed ID: 31917799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife.
    Rajah MN; Wallace LMK; Ankudowich E; Yu EH; Swierkot A; Patel R; Chakravarty MM; Naumova D; Pruessner J; Joober R; Gauthier S; Pasvanis S
    Neuroimage Clin; 2017; 14():760-774. PubMed ID: 28413778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
    Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
    Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer's disease.
    Parasoglou P; Osorio RS; Khegai O; Kovbasyuk Z; Miller M; Ho A; Dehkharghani S; Wisniewski T; Convit A; Mosconi L; Brown R
    Neuroimage Rep; 2022 Dec; 2(4):. PubMed ID: 36532654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.
    Mosconi L; Sorbi S; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Herholz K; Pupi A
    Psychiatry Res; 2004 Feb; 130(2):141-51. PubMed ID: 15033184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults.
    Johnson SC; Ries ML; Hess TM; Carlsson CM; Gleason CE; Alexander AL; Rowley HA; Asthana S; Sager MA
    Arch Gen Psychiatry; 2007 Oct; 64(10):1163-71. PubMed ID: 17909128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.
    Tao Q; Ang TFA; DeCarli C; Auerbach SH; Devine S; Stein TD; Zhang X; Massaro J; Au R; Qiu WQ
    JAMA Netw Open; 2018 Oct; 1(6):e183597. PubMed ID: 30646251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12.
    Sepulveda J; Kim JY; Binder J; Vicini S; Rebeck GW
    Mol Neurodegener; 2024 Mar; 19(1):24. PubMed ID: 38468308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
    Steward A; Biel D; Dewenter A; Roemer S; Wagner F; Dehsarvi A; Rathore S; Otero Svaldi D; Higgins I; Brendel M; Dichgans M; Shcherbinin S; Ewers M; Franzmeier N
    JAMA Neurol; 2023 Dec; 80(12):1295-1306. PubMed ID: 37930695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.
    Forno G; Contador J; Pérez-Millan A; Guillen N; Falgàs N; Sarto J; Tort-Merino A; Castellví M; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Sala-Llonch R; Sanchez-Valle R; Hornberger M; Lladó A
    Eur J Neurol; 2023 Mar; 30(3):597-605. PubMed ID: 36463489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular Dysfunction Is Central to Alzheimer's Disease Pathogenesis in APOE e4 Carriers.
    McCorkindale AN; Mundell HD; Guennewig B; Sutherland GT
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network.
    Bussy A; Snider BJ; Coble D; Xiong C; Fagan AM; Cruchaga C; Benzinger TLS; Gordon BA; Hassenstab J; Bateman RJ; Morris JC;
    Neurobiol Aging; 2019 Mar; 75():42-50. PubMed ID: 30530186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.